Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Toho Holdings CoFRA:TON 34 5-Year Yield-on-Cost % is 20.03 as of Jul. 15, 2026, which is 222% above its 10-year median of 6.23. GuruFocus rates FRA:TON with a GF Score™ of 34/100 and a GF Value™ of €26.17 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 69 Medical Distribution companies, Toho Holdings Co ranks better than 97.1% on this metric.
Toho Holdings Co's yield on cost for the quarter that ended in Mar. 2026 was 20.03.
The historical rank and industry rank for Toho Holdings Co's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:TON'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 3.55 Med: 6.23 Max: 20.89
Current: 20.03
During the past 13 years, Toho Holdings Co's highest Yield on Cost was 20.89. The lowest was 3.55. And the median was 6.23.
FRA:TON's 5-Year Yield-on-Cost % is ranked better than 97.1% of 69
companies
in the Medical Distribution industry
Industry Median: 3.76
vs FRA:TON: 20.03
Toho Holdings Co (FRA:TON) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Toho Holdings Co 5-Year Yield-on-Cost % Related Terms
FRA:TON vs MCK, CAH, COR: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Toho Holdings Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Toho Holdings Co 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Toho Holdings Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Toho Holdings Co's 5-Year Yield-on-Cost % falls into.
Toho Holdings Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Toho Holdings Co (FRA:TON) has a 5-Year Yield-on-Cost % of 20.03 as of Jul. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Toho Holdings Co and its competitors. This is 222% above median its historical median of 6.23. Over the past decade, Toho Holdings Co's 5-Year Yield-on-Cost % has ranged from 3.55 to 20.89. According to the industry distribution chart, Toho Holdings Co ranks #2 out of 69 companies in the Medical Distribution industry, placing it in the top 2.9%.
Is Toho Holdings Co's 5-Year Yield-on-Cost % too high?
Toho Holdings Co's current 5-Year Yield-on-Cost % of 20.03 is 222% above median its 10-year median of 6.23. Over the past 10 years, this metric has ranged from a low of 3.55 to a high of 20.89. The Medical Distribution industry median 5-Year Yield-on-Cost % is 3.76. Toho Holdings Co's value of 20.03 is 432.7% above this industry median. Based on the distribution chart, Toho Holdings Co ranks #2 out of 69 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Toho Holdings Co has a GF Score™ of 34/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Toho Holdings Co's 5-Year Yield-on-Cost % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Toho Holdings Co ranks #2 out of 69 companies for 5-Year Yield-on-Cost %. This places Toho Holdings Co in the top 3% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 3.76. Toho Holdings Co's value of 20.03 is 432.7% above this benchmark. Historically, Toho Holdings Co's own 5-Year Yield-on-Cost % has ranged from 3.55 to 20.89 over the past decade. While the company's 10-year median is 6.23 vs. the industry median of 3.76, Toho Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.76, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Toho Holdings Co's current 5-Year Yield-on-Cost % of 20.03 is 432.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Toho Holdings Co and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Toho Holdings Co's current 5-Year Yield-on-Cost % is 20.03, which is 222% above median its own 10-year median of 6.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Toho Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Toho Holdings Co (FRA:TON) is currently considered Modestly Undervalued. The stock's GF Value™ is €26.17, compared to a current price of €21.40 — trading 18.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 20.03, which is 222% above median its 10-year median of 6.23 and 432.7% above the Medical Distribution industry median of 3.76. Toho Holdings Co's overall GF Score™ is 34/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Toho Holdings Co (FRA:TON), the current 5-Year Yield-on-Cost % is 20.03 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Toho Holdings Co (FRA:TON) Overvalued in 2026?
Based on GuruFocus' analysis, Toho Holdings Co stock appears to be undervalued.
The current stock price of €21.40 is trading 18.2% below its estimated GF Value™ of €26.17.
GuruFocus considers Toho Holdings Co to be Modestly Undervalued.
Key valuation signals for FRA:TON:
5-Year Yield-on-Cost %: 20.03 (222% above median its 10-year median of 6.23)
GF Value™: €26.17 vs. price of €21.40 (18.2% below fair value)
Industry Position: 432.7% above the Medical Distribution median (#2 of 69)
No single metric tells the full story. See the FRA:TON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Toho Holdings Co Ltd is a specialty and generic drug manufacturing company. The company's business includes pharmaceutical wholesaling and pharmacy dispensing. It also maintains a site-management organization business that assists a variety of medical establishments, ranging from large medical institutions to private clinics, with a wide range of clinical trials under contract. The company supports medical institutions suitable for respective trials to improve the quality and speed of clinical trials. It generates additional revenue through software sales to medical institutions.
34GF Score
Get the complete analysis for FRA:TON
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:TON has been successfully added to your 
